
Varian Medical Systems, Inc. VAR
Varian Medical Systems, Inc. Gross Profit 2011-2026 | VAR
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Varian Medical Systems, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.38 B | 1.37 B | 1.27 B | 1.11 B | 1.36 B | 1.03 B | 1.3 B | 1.25 B | 1.2 B | 1.14 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.38 B | 1.03 B | 1.24 B |
Gross Profit of other stocks in the Medical instruments industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
62.4 K | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
248 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
479 K | - | -9.52 % | $ 20.6 M | ||
|
iRhythm Technologies
IRTC
|
527 M | $ 122.35 | 0.73 % | $ 3.92 B | ||
|
Alcon
ALC
|
5.74 B | $ 75.8 | -0.08 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
25.6 M | $ 3.96 | -0.75 % | $ 183 M | ||
|
Ekso Bionics Holdings
EKSO
|
6.84 M | $ 10.99 | 1.48 % | $ 26.7 M | ||
|
The Cooper Companies
COO
|
2.68 B | $ 64.42 | -0.82 % | $ 12.8 B | ||
|
Antares Pharma, Inc.
ATRS
|
86.5 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
436 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
1.68 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
1.48 B | - | -0.05 % | $ 10.3 B | ||
|
Haemonetics Corporation
HAE
|
749 M | $ 59.93 | 0.52 % | $ 3.02 B | ||
|
electroCore
ECOR
|
27.8 M | $ 6.18 | -0.08 % | $ 52.4 K | ||
|
ICU Medical
ICUI
|
822 M | $ 124.82 | 0.22 % | $ 3.08 B | ||
|
Envista Holdings Corporation
NVST
|
1.49 B | $ 26.8 | -0.89 % | $ 4.5 B | ||
|
Isoray
ISR
|
817 K | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
6.64 B | $ 482.22 | 0.71 % | $ 172 B | ||
|
Glaukos Corporation
GKOS
|
239 M | $ 121.48 | 0.5 % | $ 5.88 B | ||
|
Microbot Medical
MBOT
|
117 K | $ 2.2 | 0.92 % | $ 101 M | ||
|
STAAR Surgical Company
STAA
|
182 M | $ 25.67 | 3.34 % | $ 1.27 B | ||
|
STERIS plc
STE
|
2.4 B | $ 221.8 | -0.77 % | $ 21.9 B | ||
|
Masimo Corporation
MASI
|
1 B | $ 178.63 | -0.04 % | $ 9.52 B | ||
|
Milestone Scientific
MLSS
|
6.41 M | $ 0.32 | -1.27 % | $ 26.3 M | ||
|
InfuSystem Holdings
INFU
|
62.6 M | $ 10.34 | 0.68 % | $ 214 M | ||
|
Stereotaxis
STXS
|
17.1 M | $ 1.93 | -1.53 % | $ 176 M | ||
|
Merit Medical Systems
MMSI
|
738 M | $ 68.58 | -0.04 % | $ 4.06 B | ||
|
Teleflex Incorporated
TFX
|
307 M | $ 136.56 | -0.07 % | $ 6.09 B | ||
|
Utah Medical Products
UTMD
|
5.26 M | $ 67.17 | -1.03 % | $ 218 M | ||
|
West Pharmaceutical Services
WST
|
1.1 B | $ 306.16 | -1.14 % | $ 22.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.84 B | $ 11.91 | 0.08 % | $ 2.37 B | ||
|
Retractable Technologies
RVP
|
47 K | $ 0.65 | 0.2 % | $ 19.5 M | ||
|
Pro-Dex
PDEX
|
19.5 M | $ 52.1 | 2.24 % | $ 171 M | ||
|
LeMaitre Vascular
LMAT
|
179 M | $ 113.45 | 0.49 % | $ 2.57 B | ||
|
Predictive Oncology
POAI
|
1.02 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
18.6 M | $ 21.38 | -1.57 % | $ 985 M | ||
|
Baxter International
BAX
|
3.38 B | $ 18.16 | -1.39 % | $ 9.32 B | ||
|
ResMed
RMD
|
2.02 B | $ 219.85 | 0.15 % | $ 32.1 B | ||
|
AtriCure
ATRC
|
401 M | $ 29.28 | 3.79 % | $ 1.4 B | ||
|
Harvard Bioscience
HBIO
|
49.9 M | $ 6.86 | 1.18 % | $ 305 M | ||
|
NeuroMetrix
NURO
|
1.68 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
158 M | $ 11.1 | -0.89 % | $ 453 M | ||
|
Becton, Dickinson and Company
BDX
|
8.29 B | $ 152.14 | -1.74 % | $ 43.8 B | ||
|
Nephros
NEPH
|
8.4 M | $ 2.87 | 1.06 % | $ 29.8 M | ||
|
OraSure Technologies
OSUR
|
48.2 M | $ 3.0 | -1.64 % | $ 220 M | ||
|
Repligen Corporation
RGEN
|
151 M | $ 117.6 | 3.1 % | $ 6.55 M |